Info

Psychedelics Today

Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
RSS Feed Subscribe in Apple Podcasts
Psychedelics Today
2024
October
September
August
July
June
May
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: July, 2018
Jul 24, 2018
Download During this episode of Psychedelics Today, your hosts Joe Moore and Kyle Buller interview Dr. Monnica Williams from the University of Connecticut and Dr. Will Siu a psychiatrist IN private practice based in Manhattan,  and a therapist on MAPS’s MDMA-assisted Psychotherapy for PTSD clinical trials at the University of Connecticut. They join us to discuss race-based trauma, people of color in psychedelics, and MDMA-assisted psychotherapy.

Show Notes

About Dr. Will Siu
  • He’s a psychiatrist and therapist on the MDMA for PTSD clinical trials with the supervision of Dr. Monnica Williams.
  • Based in NYC and has a private practice.
  • Does some work in emergency psychiatry at a local hospital.
About Dr. Monnica Williams
  • Associate professor at the University of Connecticut.
  • Does graduate teaching and multicultural psychology and research in the health center.
  • Currently doing a study on MDMA assisted psychotherapy for PTSD.
  •  What is race-based trauma?
    • There had been some studies previously.
    • When people become traumatized by experiences of racism, oppression, marginalization based on their perceived identity.
    • Often because of ongoing experiences, like microaggressions
    • Eventually, people have so many of these experiences that they start to have symptoms of PTSD.
    • People get so distressed and afraid that they act in a way that might harm them.
    • You have to think about trauma in a non-single event way.
  • Exploring the topic epigenetics.
    • Trauma has been passed down from generation to generation.
    • Layer epigenetics on top of what’s currently going on and trauma is understandable.
  • How has recruiting been going for the MDMA study?
    • It’s challenging, they’re not drawing from the same population the other sites are.
    • They’re creating a culturally safe, welcoming environment for people of color.
    • There is fear and misinformation that requires them to do a lot of education on the front end.
    • Research abuses haven’t stopped, they’re still continuing today.
    • Psychedelic drugs are almost exclusively used by white people.
  • Are there any big problems you’re trying to tackle now in prepping the study?
    • Traditionally there has been no compensation for study participants, but it’s needed for this study.
    • Another layer is paying via direct deposit vs. cash and getting the university on board.
    • How do you send someone back into the trauma you’re trying to heal.
  • How do you support people in the study?
    • Support them as much as possible during the study.
    • Continue to follow-up with people after the treatment is over.
  • There is a lack of people of color in the therapy field, especially MAPS.
    • Often people of color don’t have a good experience with white therapists.
  • Why do you think there aren’t very many people of color in psychedelics?
    • People of color haven’t had the same advantages to become therapists.
      • It’s not safe to talk about substances when your license is on the line.
    • Culturally, psychedelics haven’t played as big of a role with people of color.
  • What does an ideal training model look like for you?
    • Watching the videos of people getting well was a big game changer.
    • The training needs a fuller understanding of what people from other ethnic and cultural groups need.
    • Monica is altering the training to be more relatable.
  • Talk about enrollment.
    • They have people at all different stages right now.
    • They have about 18 people total who have gone through the stages.
    • They still have to follow the guidelines of an indexed trauma to be accepted.
  • How big is your team right now?
    • Three therapist pair teams.
    • A few other people who assist in various ways.
    • Several people are doing double-duty.
  • How can the psychedelic community be more inclusive of people of color?
    • Make some close friends who are not white.
  • Do you have any fantasy projects you’d like to see play out?
    • Start a master’s program with a specialty track in minority mental health and psychedelic therapy.
    • All scholarships for people of color.
  • Any advice you’d give to a young person or professional?
    • There’s a lot of work to be done and we need enthusiastic minds.
    • Change won’t happen overnight or be easy, but it’s worth it.
    • Be involved in the community

Episode Quotes

The psychedelic community is a very, very white community - most people of color haven’t had an experience with psychedelics. Ultimately, psychedelics and psychotherapy will be an accepted, licensed form of treatment.

About Monnica Williams

   Monnica Williams, Ph.D. is a board-certified, licensed clinical psychologist, specializing in cognitive-behavioral therapies. She is an Associate Professor in the Department of Psychological Sciences at the University of Connecticut, and Director of the Laboratory for Culture and Mental Health Disparities. She is also the Clinical Director of the Behavioral Wellness Clinic, LLC in Mansfield, Connecticut, and she has founded clinics in Kentucky, Virginia, and Pennsylvania.

Will Siu, MD, DPhil

I grew up in southern California, where I completed college at UC Irvine and medical school at UCLA. Midway through medical school, I pursued research interests at the National Institutes of Health in Washington, DC and ultimately completed a doctoral degree at the University of Oxford. After finishing medical school I moved to Boston to complete my psychiatry residency at the Massachusetts General and McLean Hospitals, after which I continued to work for two years while faculty at Harvard Medical School. I moved to New York City in 2017 where in addition to having a private practice, I am a therapist on clinical trials using MDMA-assisted psychotherapy to treat PTSD.
Jul 17, 2018
Download This is a great episode featuring Daniel Greig. He is a student at the University of Toronto and psychedelic community organizer working with CSSDP and the Toronto Psychedelic Society. We go all over the map but some notable things discussed on this episode including:
  • Measuring wisdom
  • Mindfulness
  • The promise of psychedelics
  • Future research opportunities
  • How friendly the University of Toronto is to psychedelic research
  • Interesting philosophical overlaps with psychedelics and occultism
  • and much more!!
https://www.youtube.com/watch?v=5Y5qB-fgWV4

Quotes

We’re very much detached from our own traditions here in the west. Just imagining practicing something can have just as much of an effect of your performance than actually practicing it. You have to bring your insights back into the community to be an effective member of society. There’s a strong relationship between wisdom and psychedelics. Without intervention, life will tend toward suffering.

Links - Daniel Grieg

Youtube - Daniel Grieg Academia.edu Relevance realizing https://www.frontiersin.org/articles/10.3389/fphar.2017.00814/full https://www.frontiersin.org/articles/10.3389/fphar.2018.00100/full Wisdom - https://www.psychologytoday.com/us/basics/wisdom https://www.academia.edu/1762150/A_route_to_well-being_intelligence_vs._wise_reasoning http://journals.sagepub.com/doi/abs/10.1177/1948550616652206 http://www.wisdompage.com/Ardelt01.html Development Lines - Ken Wilbur Wiki Image result for ken wilber lines of development Marta Kaczmarczyk

Entity Contact

 

Paper: Mental Imagery: Functional Mechanisms and Clinical Applications

  https://www.youtube.com/watch?v=HmGNhDUe19M&t=7319s
Jul 3, 2018

Download   In this 94th episode of Psychedelics Today, host Joe Moore interviews Dr. Benjamin Malcolm, professor of pharmacy at the Western University School of Pharmacy. The discussion revolves around ibogaine, alkaloids, and addiction therapy solutions.   Show Notes:

  • Dr. Benjamin Malcolm discusses psychedelic alkaloids that have potential to treat

               addictions.

  • When conducting human subjects research, it’s a good idea to at least

   run it past an IRB.

  • There are risks involved in taking in ibogaine that can be used to treat addiction.
  • For people age 18-24, opiates are a major cause of death.
  • Holistic House teaches addicts heath habits for treatment.
  • Ibogaine is still an unregulated area.
  • 2CB haven’t had that many research studies.
  • Surveys tend to have a bit of bias, often given to supportive subjects to begin with.
  • Mescaline, San Pedro, and peyote appears to lack research.
  • There is going to be a need to potentially or switch between traditional therapeutic

  modalities and psychedelic-assisted psychotherapies.

1